The Deal Register
Database › M&A › Precision BioLogic / George King Bio-Medical

M&A

Precision BioLogic / George King Bio-Medical

Lane
M&A
Announced
16 Oct 2025
Province
Nova Scotia
Industry
Unclassified
Status
Announced
What the filing says
Precision BioLogic Inc. , a leading developer of hemostasis diagnostic products, is pleased to announce the strategic acquisition of George King Bio-Medical, Inc. , a provider of hemostasis diagnostic products with close ties to the bleeding disorders community.
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe